罗氏生化检测系统带给实验室的价值.pptVIP

血清指数对测试的影响提供可能产生的干扰数据,一目了然,使用方便 cobas 平台上: 血清指数的设置包含在试剂参数中超限时结果会有报警, 提醒该标本血清有干扰，让实验室和临床避免发出错误报告，管理成本降低 Roche 检测系统 = + 高准确性 高精密度 强抗干扰 宽广线性 实验室知名度 实验室管理成本 医院的关注 也是 的努力！ Thank you for your attention Roche Diagnostics (Shanghai) Limited Shanghai 200031 China This presentation is our intellectual property. Without our written consent, it shall neither be copied in any manner, nor used for manufacturing, nor communicated to third parties. COBAS and LIFE NEEDS ANSWERS are trademarks of Roche 在这个反应检测过程中，我们用两段动力学曲线的变化多测得的曲线进行修正，排除干扰，避免结果虚高。 * Combination of Micro-Particles of Different Size and Monoclonal Antibodies with Different Reactivity This is the first step in the quantification process - create the basis. How often does the problem occur? Slide talks about how often a sample shows a visible impact coming from Lipemia, Hemolysis and Icterus. It shows the differences in several patient groups. If a customer sees a sample with visible impact they need to make the call whether or not they can run the sample. Overall about 9 - 10 % of all samples show a visible impact. Lipemia occurs most frequently in outpatients. Although patients are often asked to fast before they get their blood drawn, they might not follow this advice that strictly. While for the hospitalized patient who is under a much more controlled situation, lipemia is significantly reduced. Hemolysis occurs much more frequently with hospitalized patients. The reason for this is most likely that you are dealing with sick patients who tend to have a higher rate of hemolysis occurring than a healthy patient. Icterus - also occurs most frequently with the sick patient. For the lab the issues are: identify the samples which cannot be run, because amount of interfering substance will cause a wrong result. Some chemistries are heavily interfered, some less, some not at all. So the decision needs to made on the level of chemistry. * 罗氏生化检测系统带给实验室的价值 Tina Yan , Roche Training